Johannes Textor

Department of Medical Biosciences, Radboudumc

Affiliated withRadboudumc Radboud University

Research Area

Cancer Research

Biography

Johannes Textor has not added Biography.
If you are Johannes Textor and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 7	2023

Other Publications

Article	Year
T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines. Cancer research\| PubMed ID: 27197179	2016
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients. Oncoimmunology\| PubMed ID: 27622047	2016
The Reticular Cell Network: A Robust Backbone for Immune Responses. PLoS biology\| PubMed ID: 27727272	2016
Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy. Oncotarget\| PubMed ID: 28186996	2017
Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 29141863	2018
Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case Report. Frontiers in oncology\| PubMed ID: 30555799	2018
Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination. Cell reports\| PubMed ID: 31995747	2020
Is T Cell Negative Selection a Learning Algorithm? Cells\| PubMed ID: 32168897	2020
Testing Graphical Causal Models Using the R Package "dagitty". Current protocols\| PubMed ID: 33592130	2021
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming. European journal of immunology\| PubMed ID: 33675038	2021
Local actin dynamics couple speed and persistence in a cellular Potts model of cell migration. Biophysical journal\| PubMed ID: 34022237	2021
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery. Journal for immunotherapy of cancer\| PubMed ID: 34059522	2021
Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer. Frontiers in oncology\| PubMed ID: 34084750	2021
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nature communications\| PubMed ID: 34471116	2021
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar ... Journal for immunotherapy of cancer\| PubMed ID: 35550553	2022
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination. Journal for immunotherapy of cancer\| PubMed ID: 36252995	2022
Interpreting T-cell search "strategies" in the light of evolution under constraints. PLoS computational biology\| PubMed ID: 36848395	2023
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications\| PubMed ID: 37095077	2023